Dezheng (Dawson) Dong, MD，PhD 

Dezheng（Dawson）Dong，MD，PhD 

Dezheng（Dawson） Dong is the board member of California Regency University in

Los Angeles. Dr.Dong is the founder and Chairman of American Golden Tripod

Organization(AGTO)，Chairman of America Cultural Center of Chinese Minorities，

the Vice Chairman of International Association of Bio-Medical Sciences (IABMS). Dr.

Dong has considerable experience in business development and marketing and in

medical research. Dr. Dong was born in Harbin, China. He has studied, conducted

medical research, and worked at Harvard Medical School and at the University of

Southern California，Bethune Medical University, Harbin Medical University,

Shanghai Second Medical University, Dokkyo Medical University. He currently lives

in Los Angeles and dedicates his time to his family, supports the world education

system and health care industry, develops social networks, becomes a financial

advisor of World Financial Group. During this period he published a number of

articles to include:

1.Borra R, Dong D, Elnagar AY, Woldemariam GA, Camarero JA. In-cell fluorescence

activation and labeling of proteins mediated by FRET-quenched split inteins J Am

Chem Soc 2012 134(14):6344-53.

2.Dong D, et al. A Critical Role for GRP78/BiP in the Tumor Microenvironment for

Neovascularization during Tumor Growth and Metastasis. Cancer Res. 2011 Apr

15;71(8):2848-57.

3.Baumeister P, Dong D, Fu Y, Lee AS. Transcriptional induction of GRP78/BiP by

ihistone deacetylase inhibitors and resistance to histone deacetylase inhibitor[1]

induced apoptosis. Mol Cancer Ther.2009;8(5):1089-94.

4.Virrey JJ, Dong D, Stiles C, Patterson JB, Pen L, Ni M, Schönthal AH, Chen TC,

Hofman FM, Lee AS. Stress Chaperone GRP78/BiP Confers Chemoresistance To

Glioma-Associated Brain Endothelial Cells. Mol Cancer Res 2008;6 1268-1275

1. Dong D, et al. Critical role of the stress chaperone GRP78/BiP in tumor

proliferation, survival, and tumor angiogenesis in transgene-induced mammary

tumor development. Cancer Res. 2008 Jan 15;68(2):498-505.

6.Dong D, Ko B, Baumeister P, Swenson S, Costa F, Markland F, Stiles C, Patterson JB,

Bates SE, Lee AS. Vascular targeting and antiangiogenesis agents induce drug

resistance effector GRP78 within the tumor microenvironment. Cancer Res.

2005;65(13):5785-91.

7.Dong D, et al. Spontaneous and controllable activation of suicide gene expression

driven by the stress-inducible grp78 promoter resulting in eradication of sizable

human tumors. Hum Gene Ther. 2004;15(6):553-61.

8.Mao C, Dong D, Little E, Luo S, Lee AS. Transgenic mouse model for monitoring

endoplasmic reticulum stress in vivo. Nat Med. 2004;10(10):1013-4.